Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01880021 · ClinicalTrials.gov registry record
Synthetic Mesh Explant Study
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 111
- Enrollment target
NCT01880021: Completed study, sponsored by Washington University School of Medicine.
NCT01880021 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 111 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01880021 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 111 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether synthetic hernia mesh materials undergo physical and/or chemical changes while in the body.
Primary Outcome
Each specimen will be graded and given fibrosis score of 0 - 4 to establish the degree of inflammation/foreign body reaction that occurred while mesh was in vivo.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2008-03 |
| Est. Completion | 2016-09 |
What the finished NCT01880021 record still lists
NCT01880021 is an observational study that tracks outcomes without assigning an intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01880021 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01880021 about?
NCT01880021 is a clinical study titled "Synthetic Mesh Explant Study". The purpose of this study is to determine whether synthetic hernia mesh materials undergo physical and/or chemical changes while in the body.
What is the current status of trial NCT01880021?
This trial is currently completed. The enrollment target is 111 participants. The study started on 2008-03. Estimated completion is 2016-09.
Who is sponsoring clinical trial NCT01880021?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia